Pressemeldungen

International MOU inked between chemistry and biomedical talents from Hong Kong, Singapore and Europe for late-stage cancer research enhancement.

READ MORE >

Juli 27, 2022

Annals of Oncology – ESMO Abstract 233P

READ MORE >

Mai 20, 2022

ESMO Breast Cancer 2022, Berlin, Germany

READ MORE >

April 27, 2022

Webinar – New Trends in Drug Discovery : Robotics and AI

READ MORE >

Oktober 12, 2020

The war against cancer will be fought better with improved decision making tools

READ MORE >

Dezember 11, 2019

Invitrocue Establishes Hong Kong Laboratory

READ MORE >

Oktober 21, 2019

Invitrocue Clinical Studies underway in Germany

READ MORE >

Oktober 21, 2019

Collaboration with National University Hospital Singapore

READ MORE >

September 9, 2019

Invitrocue Appoints Global Insurance Advisor

READ MORE >

Mai 6, 2019

Invitrocue Appoints Professor Arial Zeng Yi as Patient Derived Organoid Consultant

READ MORE >

Februar 19, 2019

Invitrocue creates Joint Venture with A*STAR scientist Dr. Chen Qingfeng

READ MORE >

Februar 11, 2019

IVQ technology development agreement with SIBCB on breast cancer.

READ MORE >

Januar 23, 2019

Invitrocue roll-out of Onco-PDO services in Germany

READ MORE >

Januar 21, 2019

Invitrocue Appoints Renowned Oncology Researcher Professor Jesús García-Foncillas as Clinical Advisor

READ MORE >

Januar 15, 2019

Invitrocue Appoints Professor Masakazu Toi as Clinical Advisor

READ MORE >

Januar 11, 2019

Invitrocue announced Board Changes

READ MORE >

Januar 9, 2019

Invitrocue – 50 Top Investment Ideas for 2019 – The Australian Newspaper

READ MORE >

Januar 2, 2019

Invitrocue's Steven Fang: Insights into the Asian Biopharma Market

READ MORE >

Dezember 3, 2018

Results of Annual General Meeting

READ MORE >

November 30, 2018

Change of Director's Interest Notice

READ MORE >

November 26, 2018

Dr Lindner as Europe CEO and Prof Waugh as Senior Advisor

READ MORE >

November 19, 2018

Biotech Investment Summit @ Singapore

READ MORE >

Oktober 31, 2018

Symposium: "Oncology: The future of cancer treatment"

READ MORE >

Oktober 22, 2018

Assoc Prof Iyer as Chair of IVQ Medical Advisory Board

READ MORE >

Oktober 22, 2018

Annual Report to shareholders

READ MORE >

September 28, 2018

Oncology: The future of cancer treatment

READ MORE >

September 13, 2018

Business updates

READ MORE >

September 4, 2018

IVQ launches Personalised Cancer Screening Service Onco-PDO

READ MORE >

April 13, 2018

Invitrocue unveils novel cancer detection method, screens first customer in Singapore

READ MORE >

April 13, 2018

Half Yearly Report and Accounts

READ MORE >

Februar 28, 2018

Grant from Northern Ireland to commercialize Onco-PDO

READ MORE >

Februar 26, 2018

Investor Presentation

READ MORE >

Februar 23, 2018

Change of Director's Interest Notice – Jamie Khoo

READ MORE >

Februar 20, 2018

Change of Director's Interest Notice – Steven Fang

READ MORE >

Februar 20, 2018

Change of Director's Interest Notice

READ MORE >

Februar 14, 2018

Change of Director's Interest Notice

READ MORE >

Februar 14, 2018

Change of Director's Interest Notice

READ MORE >

Februar 14, 2018

Change of Director's Interest Notice

READ MORE >

Februar 14, 2018

Change of Director's Interest Notice

READ MORE >

Februar 14, 2018

IVQ successfully grows liver cancer organoids

READ MORE >

Januar 18, 2018

2017 AGM Presentation

READ MORE >

November 30, 2017

IVQ receives award from Singapore government IP office

READ MORE >

August 29, 2017

Launch of New Joint Innovation Laboratory to Advance Personalised Medicine for Cancer Treatment

READ MORE >

Juli 24, 2017

Invitrocue to work with Garvan Institute to Progress Personalised Real-time Screening of Cancer Drugs

READ MORE >

Juli 3, 2017

Invitrocue Expands Into In-Vitro Skin and Wound Healing Assays

READ MORE >

Mai 22, 2017

A*STAR TV Business Insider – The Story of Invitrocue

READ MORE >

Mai 5, 2017

Asia Malaria Images Exhibition

READ MORE >

März 22, 2017

Singapore-Australia Cooperation on Science and Technology Takes Off

READ MORE >

März 14, 2017

Second Mention in Speech by Minister Iswaran at the Official Opening of the Australian Landing Pad in Singapore

READ MORE >

März 13, 2017

First Mention in Committee of Supply Debate by Ministry of Trade and Industry

READ MORE >

März 4, 2017

Invitrocue Signs Research Collaboration Agreement with the Garvan Institute of Medical Research

READ MORE >

Februar 23, 2017

Annual General Meeting 2016

READ MORE >

Oktober 28, 2016

Invitrocue Signs Research Collaboration Agreement with Genome Institute of Singapore for Colorectal Cancer Organoids

READ MORE >

Oktober 24, 2016

InvitroCue Awarded A*STAR Tender

READ MORE >

September 6, 2016

InvitroCue Signs Strategic Partnership Agreement With QIAGEN Suzhou

READ MORE >

August 22, 2016

InvitroCue Announces New Program Focused on Hepatitis B Virus

READ MORE >

Juli 28, 2016

InvitroCue Commences Pancreatic Toxicity Assay Development

READ MORE >

Juli 11, 2016

Investor Presentation (Mandarin)

READ MORE >

Juni 14, 2016

InvitroCue Announces Malaria Initiative

READ MORE >

Mai 16, 2016

InvitroCue Expands 3D Cell-based Platform for Oncology

READ MORE >

Mai 12, 2016

InvitroCue and SciKon Innovation Forge an Alliance to Create the Future of Perfused Human Liver Tissue

READ MORE >

April 8, 2016

InvitroCue Launches Cellacyl: Proprietary Acyl Glucuronide Detection Assay

READ MORE >

April 8, 2016

InvitroCue – A Singapore-based Startup That Is Transforming Bioanalytics

READ MORE >

März 14, 2016

Agreement with London School of Hygiene & Tropical Medicine

READ MORE >

März 9, 2016

Novel 3D in vitro Techniques for Modeling leishmaniasis

READ MORE >

März 9, 2016

Bioanalytics Start-up InvitroCue is Preparing for the Global Stage

READ MORE >

März 5, 2016

InvitroCue Expands Cell-based Lab in Suzhou to Meet Client’s Increase China Focus

READ MORE >

März 5, 2016

InvitroCue Participates in Society of Toxicology Annual Meeting and ToxExpo

READ MORE >

Februar 15, 2016

New Consortium on NASH Pilots Organ Function-on-a-Chip

READ MORE >

Februar 15, 2016

Artificial Human Liver Developed for Drug Testing

READ MORE >

Februar 5, 2016

InvitroCue Holds Targeted Investor Road Show on 15 February

READ MORE >

Februar 4, 2016

InvitroCue Takes Tech Licensed From A*STAR To Market

READ MORE >

Februar 2, 2016

Regional Liver Cancer Registry To Be Set Up

READ MORE >

Februar 2, 2016

ImageIQ And InvitroCue Forge Partnership To Advance Quantitative Image Analysis For Preclinical Researchers In Asia

READ MORE >

Februar 1, 2016

80% Of Liver Cancer Patients Are In Asia

READ MORE >

Januar 30, 2016

NCCS And InvitroCue To Develop Quantitative Cancer Imaging And Radiomics Applications For Treatment Of Liver Cancer Patients

READ MORE >

Januar 28, 2016

InvitroCue and Swiss InSphero MOU Signing Ceremony

READ MORE >

April 8, 2015

How can we address your interest?I am..

READ MORE >

Mai 15, 1990